• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT Back to Search Results
Catalog Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ischemia (1942); Pain (1994); Obstruction/Occlusion (2422); Tissue Breakdown (2681)
Event Type  Injury  
Event Description
Zamani et al 2020 ¿ (zilver ptx)¿outcomes after endovascular stent placement for long-segment superficial femoral artery lesions¿.All cases were either primarily stented or followed angioplasty when the degree of residual stenosis exceeded 50% or when a flow-limiting dissection was identified.Technical success was defined as re-establishment of sfa patency with flow across the target lesion with less than 30% re-sidual stenosis on completion angiography.The des (n=57) was self-expanding nitinol stents with a polymer-free pacli-taxel coating (zilver ptx; cook medical, blooming-ton, in).Target lesion revascularization.Symptoms at stent occlusion included claudication (4), rest pain or tissue loss (6) and acute limb ischemia (ali) (1).Stented lesions collectively required 11 endovascular and 2 open revasculatization attempts.The vast majority of both endovascular and open reinterventions occurred within 18 months of initial stent placement.Among the cases with ali, 8 (47% of overall cohort) required an open arterial bypass of the target lesion, all of whom were in patients initially treated with cs.
 
Manufacturer Narrative
Common device name: niu stent, superficial femoral artery, drug-eluting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
MDR Report Key13151116
MDR Text Key288488801
Report Number3005580113-2022-00007
Device Sequence Number1
Product Code NIU
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 12/29/2021,01/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/04/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date12/08/2021
Event Location Hospital
Date Report to Manufacturer12/29/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient SexMale
-
-